0
0
The US medical regulator recommended limiting the use of the JJ vaccine for COVID-19 The US Food and Drug Administration (FDA) announced that
The US medical regulator recommended limiting the use of the JJ vaccine against COVID-19
The US Food and Drug Administration (FDA) has announced that it is restricting the use of the Johnson Johnson (JJ) COVID-19 vaccine for adults due to the risk of developing blood clotting syndrome, Trend reports citing Interfax.
The recommendations were issued based on an investigation into reported cases of thrombosis following JJ vaccinations.
JJ is one of the coronavirus vaccines used in the United States along with Moderna and Pfizer. It requires only one dose, while Moderna and Pfizer require two doses.
JJ was approved for use in the US in February 2021 for adults and may be given when Moderna and Pfizer are not available, or if the person is not interested in two doses.
The US Centers for Disease Control and Prevention (CDC) in December last year recommended Pfizer and Moderna vaccines to Americans instead of JJ due to cases of thrombosis with thrombocytopenia syndrome after its administration, media reported, commenting on the recommendations of the regulator.
About 18.7 million Americans have been vaccinated against COVID-19 JJ, according to the CDC. Vaccines Moderna vaccinated 217.5 million, Pfizer – 340.6 million.
